Bridging the gap between education and appropriate use of benzodiazepines in psychiatric clinical practice

References

• de WitHGriffithsRRTesting the abuse liability of anxiolytic and hypnotic drugs in humansDrug Alcohol Depend1991281831111679388
   PubMed Web of Science ®Google Scholar
• GriffithsRRWolfBRelative abuse liability of different benzodiazepines in drug abusersJ Clin Psychopharmacol19901042372431981067
   PubMed Web of Science ®Google Scholar
• AbernethyDRGreenblattDJOchsHRShaderRIBenzodiazepine drug-drug interactions commonly occurring in clinical practiceCurr Med Res Opin19848Suppl 480936144465
   PubMed Web of Science ®Google Scholar
• JonesKANielsenSBrunoRFreiMLubmanDIBenzodiazepines – their role in aggression and why GPs should prescribe with cautionAust Fam Physician2011401186286522059213
   PubMed Web of Science ®Google Scholar
• SellersEMBustoUBenzodiazepines and ethanol: assessment of the effects and consequences of psychotropic drug interactionsJ Clin Psychopharmacol1982242492626126493
   PubMed Web of Science ®Google Scholar
• LinnoilaMIBenzodiazepines and alcoholJ Psychiatr Res199024Suppl 21211271980691
   PubMed Web of Science ®Google Scholar
• LaderMBenzodiazepines revisited – will we ever learn?Addiction2011106122086210921714826
   PubMed Web of Science ®Google Scholar
• Dell’OssoBLaderMDo benzodiazepines still deserve a major role in the treatment of psychiatric disorders? A critical reappraisalEur Psychiatry201328172022521806
   PubMed Web of Science ®Google Scholar
• BaldwinDSAitchisonKBatesonABenzodiazepines: risks and benefits. A reconsiderationJ Psychopharmacol2013271196797124067791
   PubMed Web of Science ®Google Scholar
• FieveRRLithium therapy at the millennium: a revolutionary drug used for 50 years faces competing options and possible demiseBipolar Disord199912677011252660
   PubMedGoogle Scholar
• MajMLithium: the forgotten drug?McDonaldCSchultzeKMurrayRMTohenMBipolar Disorder: The Upswing in Research and TreatmentAbingdon, UKTaylor and Francis2005176179
   Google Scholar
• FiorilloAMalikALucianoMChallenges for trainees in psychiatry and early career psychiatristsInt Rev Psychiatry201325443143724032498
   PubMed Web of Science ®Google Scholar
• MugunthanKMcGuireTGlasziouPMinimal interventions to decrease long-term use of benzodiazepines in primary care: a systematic review and meta-analysisBr J Gen Pract201161590e573e57822152740
   PubMed Web of Science ®Google Scholar
• HewlettWAVinogradovSAgrasWSClomipramine, clonazepam, and clonidine treatment of obsessive-compulsive disorderJ Clin Psychopharmacol19921264204301474179
   PubMed Web of Science ®Google Scholar
• HollanderEKaplanAStahlSMA double-blind, placebo-controlled trial of clonazepam in obsessive-compulsive disorderWorld J Biol Psychiatry200341303412582975
   PubMed Web of Science ®Google Scholar
• SteinDJHollanderEMullenLSDeCariaCMLiebowitzMRComparison of clomipramine, alprazolam, and placebo in the treatment of obsessive-compulsive disorderHum Psychopharmacol199276389395
   Web of Science ®Google Scholar
• KatzmanMABleauPBlierPCanadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disordersBMC Psychiatry201414Suppl 1S125081580
   PubMed Web of Science ®Google Scholar
• KoranLMAboujaoudeEBullockKDDouble-blind treatment with oral morphine in treatment-resistant obsessive-compulsive disorderJ Clin Psychiatry200566335335915766302
   PubMed Web of Science ®Google Scholar
• CrockettBAChurchillEDavidsonJRA double-blind combination study of clonazepam with sertraline in obsessive-compulsive disorderAnn Clin Psychiatry200416312713215517844
   PubMedGoogle Scholar
• Van AmeringenMSimpsonWPattersonBPharmacological treatment strategies in obsessive-compulsive disorder: a cross-sectional view in nine international OCD centersJ Psychopharmacol201428659660224429223
   PubMed Web of Science ®Google Scholar
• BraunPGreenbergDDasbergHLererBCore symptoms of post-traumatic stress disorder unimproved by alprazolam treatmentJ Clin Psychiatry19905162362382189869
   PubMed Web of Science ®Google Scholar
• CatesMEBishopMHDavisLLLoweJSWoolleyTWClonazepam for treatment of sleep disturbances associated with combat-related posttraumatic stress disorderAnn Pharmacother20043891395139915252193
   PubMed Web of Science ®Google Scholar
• BandelowBZoharJHollanderEWorld Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders – first revisionWorld J Biol Psychiatry20089424831218949648
   PubMed Web of Science ®Google Scholar
• BandelowBSherLBuneviciusRWFSBP Task Force on Mental Disorders in Primary CareWFSBP Task Force on Anxiety Disorders, OCD and PTSDGuidelines for the pharmacological treatment of anxiety disorders, obsessive-compulsive disorder and posttraumatic stress disorder in primary careInt J Psychiatry Clin Pract2012162778422540422
   PubMed Web of Science ®Google Scholar
• BaldwinDSAndersonIMNuttDJEvidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: a revision of the 2005 guidelines from the British Association for PsychopharmacologyJ Psychopharmacol201428540343924713617
   PubMed Web of Science ®Google Scholar
• ZoharJJuven-WetzlerASonninoRCwikel-HamzanySBalabanECohenHNew insights into secondary prevention in post-traumatic stress disorderDialogues Clin Neurosci201113330130922033784
   PubMedGoogle Scholar
• GelpinEBonneOPeriTBrandesDShalevAYTreatment of recent trauma survivors with benzodiazepines: a prospective studyJ Clin Psychiatry19965793903949746445
   PubMed Web of Science ®Google Scholar
• MellmanTABustamanteVDavidDFinsAIHypnotic medication in the aftermath of traumaJ Clin Psychiatry200263121183118412530420
   PubMed Web of Science ®Google Scholar
• MatarMAZoharJKaplanZCohenHAlprazolam treatment immediately after stress exposure interferes with the normal HPA-stress response and increases vulnerability to subsequent stress in an animal model of PTSDEur Neuropsychopharmacol200919428329519167197
   PubMed Web of Science ®Google Scholar
• US Department of Veterans AffairsClinical practice guideline for management of post-traumatic stressWashington, DC, USADepartment of Defense, Quality Management Division, United States Army2010 Available from: http://www.healthquality.va.gov/guidelines/MH/ptsd/Accessed June 6, 2015
   Google Scholar
• American Psychiatric AssociationDiagnostic and Statistical Manual of Mental DisordersFifth EditionWashington, DC, USAAmerican Psychiatric Association2013
   Google Scholar
• CarmassiCAkiskalHSBessonovDGender differences in DSM-5 versus DSM-IV-TR PTSD prevalence and criteria comparison among 512 survivors to the L’Aquila earthquakeJ Affect Disord20141605556124709023
   PubMed Web of Science ®Google Scholar
• CarmassiCAkiskalHSYongSSPost-traumatic stress disorder in DSM-5: estimates of prevalence and criteria comparison versus DSM-IV-TR in a non-clinical sample of earthquake survivorsJ Affect Disord2013151384384824135508
   PubMed Web of Science ®Google Scholar
• LundBCBernardyNCVaughan-SarrazinMAlexanderBFriedmanMJPatient and facility characteristics associated with benzodiazepine prescribing for veterans with PTSDPsychiatr Serv201364214915523154834
   PubMed Web of Science ®Google Scholar
• UrsanoRJBellCEthSPractice guideline for the treatment of patients with acute stress disorder and posttraumatic stress disorderAm J Psychiatry200416111 Suppl33115617511
   PubMed Web of Science ®Google Scholar
• LeeHSLeeHPLeeSKKimYKChoiYKAnti-intrusion effect of lorazepam: an experimental studyPsychiatry Investig2013103273280
   Web of Science ®Google Scholar
• CapehartBPBenzodiazepines, posttraumatic stress disorder, and veterans: good news and why we’re not done yetJ Clin Psychiatry201273330730922490258
   PubMed Web of Science ®Google Scholar
• UhlenhuthEHBalterMBBanTAYangKInternational study of expert judgment on therapeutic use of benzodiazepines and other psychotherapeutic medications: VI. Trends in recommendations for the pharmacotherapy of anxiety disorders, 1992–1997Depress Anxiety19999310711610356648
   PubMedGoogle Scholar
• BandelowBBaldwinDSZwanzgerPPharmacological treatment of panic disorderMod Trends Pharmacopsychiatry201329128143
   Google Scholar
• BandelowBLichteTRudolfSWiltinkJBeutelMEThe diagnosis of and treatment recommendations for anxiety disordersDtsch Arztebl Int201411127–2847348025138725
   PubMed Web of Science ®Google Scholar
• BatelaanNMVan BalkomAJSteinDJEvidence-based pharmacotherapy of panic disorder: an updateInt J Neuropsychopharmacol201215340341521733234
   PubMed Web of Science ®Google Scholar
• FreireRCMachadoSArias-CarriónONardiAECurrent pharmacological interventions in panic disorderCNS Neurol Disord Drug Targets20141361057106524923349
   PubMed Web of Science ®Google Scholar
• OffidaniEGuidiJTombaEFavaGAEfficacy and tolerability of benzodiazepines versus antidepressants in anxiety disorders: a systematic review and meta-analysisPsychother Psychosom201382635536224061211
   PubMed Web of Science ®Google Scholar
• BerneyPHalperinDTangoRDaeniker-DayerISchulzPA major change of prescribing pattern in absence of adequate evidence: benzodiazepines versus newer antidepressants in anxiety disordersPsychopharmacol Bull2008413394718779775
   PubMedGoogle Scholar
• AlbertUDe CoriDBogettoFGeneralized anxiety disorderMarazzitiDClinical PsychopharmacologyRome, ItalyGiovanni Fioriti Editore20137786 Italian
   Google Scholar
• StarcevicVThe reappraisal of benzodiazepines in the treatment of anxiety and related disordersExpert Rev Neurother201414111275128625242262
   PubMed Web of Science ®Google Scholar
• BlancoCBragdonLBSchneierFRLiebowitzMRThe evidence-based pharmacotherapy of social anxiety disorderInt J Neuropsychopharmacol201316123524922436306
   PubMed Web of Science ®Google Scholar
• SteinDJSeedatSUnresolved questions about treatment-resistant anxiety disordersCNS Spectr200491071515448582
   PubMed Web of Science ®Google Scholar
• PollackMHVan AmeringenMSimonNMA double-blind randomized controlled trial of augmentation and switch strategies for refractory social anxiety disorderAm J Psychiatry20141711445324399428
   PubMed Web of Science ®Google Scholar
• HäuserWWalittBFitzcharlesAMSommerCReview of pharmacological therapies in fibromyalgia syndromeArthritis Res Ther201416120124433463
   PubMed Web of Science ®Google Scholar
• PorcelliPDe CarneMNon-fearful panic disorder in gastroenterologyPsychosomatics200849654354519122134
   PubMed Web of Science ®Google Scholar
• LunnMPHughesRAWiffenPJDuloxetine for treating painful neuropathy, chronic pain or fibromyalgiaCochrane Database Syst Rev20141CD00711524385423
   PubMed Web of Science ®Google Scholar
• KawataHOkaTThe use of psychotropic drugs for functional gastrointestinal disorders: are they beneficial?Nihon Rinsho20127018488 Japanese22413498
   PubMedGoogle Scholar
• DonoghueJLaderMUsage of benzodiazepines: a reviewInt J Psychiatry Clin Pract2010142788724922466
   PubMed Web of Science ®Google Scholar
• TariqSHPulisettySPharmacotherapy for insomniaClin Geriatr Med20082419310518035234
   PubMed Web of Science ®Google Scholar
• DittoniSMazzaMLosurdoAPsychological functioning measures in patients with primary insomnia and sleep state misperceptionActa Neurol Scand20131281546023406317
   PubMed Web of Science ®Google Scholar
• American Academy of Sleep MedicineInternational Classification of Sleep Disorders. Diagnostic and Coding Manual2nd edWestchester, IL, USAAmerican Academy of Sleep Medicine2005
   Google Scholar
• Schutte-RodinSBrochLBuysseDClinical guideline for the evaluation and management of chronic insomnia in adultsJ Clin Sleep Med20084548750418853708
   PubMed Web of Science ®Google Scholar
• WilsonSJNuttDJAlfordCBritish Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disordersJ Psychopharmacol201024111577160120813762
   PubMed Web of Science ®Google Scholar
• PassarellaSDuongMTDiagnosis and treatment of insomniaAm J Health Syst Pharm2008651092793418463341
   PubMed Web of Science ®Google Scholar
• ErmanMKBenzodiazepine receptor agonistsCNS SpectrumsThe Black Book of InsomniaNew YorkMBL Communication20092427
   Google Scholar
• SalzmanCPharmacologic treatment of disturbed sleep in the elderlyHarv Rev Psychiatry200816527127818803102
   PubMed Web of Science ®Google Scholar
• MorinCMColecchiCStoneJSoodRBrinkDBehavioral and pharmacological therapies for late-life insomnia: a randomized controlled trialJAMA19992811199199910086433
   PubMed Web of Science ®Google Scholar
• TanKRBrownMLabouebeGNeural bases for addictive properties of benzodiazepinesNature2010463728276977420148031
   PubMed Web of Science ®Google Scholar
• ParrinoLBoselliMSpaggiariMCSmerieriATerzanoMGMultidrug comparison (lorazepam, triazolam, zolpidem, and zopiclone) in situational insomnia: polysomnographic analysis by means of the cyclic alternating patternClin Neuropharmacol19972032532639197949
   PubMed Web of Science ®Google Scholar
• BastienCHLeBlancMCarrierJMorinCMSleep EEG power spectra, insomnia, and chronic use of benzodiazepinesSleep200326331331712749551
   PubMed Web of Science ®Google Scholar
• MazzaMLosurdoATestaniEPolysomnographic findings in a cohort of chronic insomnia patients with benzodiazepine abuseJ Clin Sleep Med2014101354224426818
   PubMed Web of Science ®Google Scholar
• SimFSweetmanIKapurSPatelMXRe-examining the role of benzodiazepines in the treatment of schizophrenia: a systematic reviewJ Psychopharmacol201529221222325049261
   PubMed Web of Science ®Google Scholar
• DoldMLiCGilliesDLeuchtSBenzodiazepine augmentation of antipsychotic drugs in schizophrenia: a meta-analysis and Cochrane review of randomized controlled trialsEur Neuropsychopharmacol20132391023103323602690
   PubMed Web of Science ®Google Scholar
• LangleGSteinertTWeiserPEffects of polypharmacy on outcome in patients with schizophrenia in routine psychiatric treatmentActa Psychiatr Scand2012125537238122321029
   PubMed Web of Science ®Google Scholar
• GallegoJABonettiJZhangJKaneJMCorrellCUPrevalence and correlates of antipsychotic polypharmacy: a systematic review and meta-regression of global and regional trends from the 1970s to 2009Schizophr Res20121381182822534420
   PubMed Web of Science ®Google Scholar
• CorrellCUShaikhLGallegoJAAntipsychotic polypharmacy: a survey study of prescriber attitudes, knowledge and behaviourSchizophr Res20111311–3586221419603
   PubMed Web of Science ®Google Scholar
• PickarDVinikJBartkoJJPharmacotherapy of schizophrenic patients: preponderance of off-label drug usePLoS One200839e315018781198
   PubMed Web of Science ®Google Scholar
• TREC Collaborative GroupRapid tranquillisation for agitated patients in emergency psychiatric rooms: a randomized trial of midazolam versus haloperidol plus promethazineBMJ2003327741770871314512476
   PubMed Web of Science ®Google Scholar
• BuchananRWKreyenbuhlJKellyDLThe 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statementsSchizophr Bull2010361719319955390
   PubMed Web of Science ®Google Scholar
• LehmanAFLiebermanJADixonLBAmerican Psychiatric Association, Steering Committee on Practice Guidelines. Practice guideline for the treatment of patients with schizophrenia, second editionAm J Psychiatry20041612 Suppl15615000267
   PubMed Web of Science ®Google Scholar
• HeresSDonLHercegMTreatment of acute schizophrenia with paliperidone ER: predictors for treatment response and benzodiazepine useProg Neuropsychopharmacol Biol Psychiatry201434820721224096139
   PubMed Web of Science ®Google Scholar
• GilliesDSampsonSBeckARathboneJBenzodiazepines for psychosis-induced aggression or agitationCochrane Database Syst Rev20139CD00307924049046
   PubMedGoogle Scholar
• TiihonenJSuokasJTSuvisaariJMHaukkaJKorhonenPPolypharmacy with antipsychotics, antidepressants, or benzodiazepines and mortality in schizophreniaArch Gen Psychiatry201269547648322566579
   PubMed Web of Science ®Google Scholar
• BaandrupLGasseCJensenVDAntipsychotic polypharmacy and risk of death from natural causes in patients with schizophrenia: a population-based nested case-control studyJ Clin Psychiatry201071210310819895781
   PubMed Web of Science ®Google Scholar
• BirkenhagerTKMolemanPNolenWABenzodiazepines for depression? A review of the literatureInt Clin Psychopharmacol19951031811958675972
   PubMed Web of Science ®Google Scholar
• ValensteinMTaylorKKAustinKKalesHCMcCarthyJFBlowFCBenzodiazepine use among depressed patients treated in mental health settingsAm J Psychiatry2004161465466115056511
   PubMed Web of Science ®Google Scholar
• SmithWTLondborgPDGlaudinVPainterJRShort-term augmentation of fluoxetine with clonazepam in the treatment of depression: a double-blind studyAm J Psychiatry199815510133913459766764
   PubMed Web of Science ®Google Scholar
• LondborgPDSmithWTGlaudinVPainterJRShort-term cotherapy with clonazepam and fluoxetine: anxiety, sleep disturbance and core symptoms of depressionJ Affect Disord2000611–2737911099743
   PubMed Web of Science ®Google Scholar
• FurukawaTAStreinerDLYoungLTAntidepressant plus benzodiazepine for major depressionCochrane Database Syst Rev20012CD00102611405972
   PubMedGoogle Scholar
• BeekmanATde BeursEvan BalkomAJDeegDJvan DyckRvan TilburgWAnxiety and depression in later life: co-occurrence and communality of risk factorsAm J Psychiatry20001571899510618018
   PubMed Web of Science ®Google Scholar
• BerkMSelective serotonin reuptake inhibitors in mixed anxiety-depressionInt Clin Psychopharmacol200015Suppl 2S41S4511110018
   PubMed Web of Science ®Google Scholar
• McAndrewsMWeissRTSandorPTaylorACarlenPLShapiroCMCognitive effects of long-term benzodiazepine use in older adultsHum Psychopharmacol2003181515712532315
   PubMed Web of Science ®Google Scholar
• FastbomJForsellYWinbladBBenzodiazepines may have protective effects against Alzheimer diseaseAlzheimer Dis Assoc Disord199812114179539405
   PubMed Web of Science ®Google Scholar
• PaternitiSDufouilCAlperovitchALong-term benzodiazepine use and cognitive decline in the elderly: the epidemiology of vascular aging studyJ Clin Psychopharmacol200222328529312006899
   PubMed Web of Science ®Google Scholar
• OlfsonMMarcusSCDrussBElinsonLTanielianTPincusHANational trends in the outpatient treatment of depressionJAMA2002287220320911779262
   PubMed Web of Science ®Google Scholar
• BerlimMTTureckiGWhat is the meaning of treatment resistant/refractory major depression (TRD)? A systematic review of current randomized trialsEur Neuropsychopharmacol2007171169670717521891
   PubMed Web of Science ®Google Scholar
• MorishitaSClonazepam as a therapeutic adjunct to improve the management of depression: a brief reviewHum Psychopharmacol200924319119819330803
   PubMed Web of Science ®Google Scholar
• FavaMAlpertJECarminCNClinical correlates and symptom patterns of anxious depression among patients with major depressive disorder in STAR*DPsychol Med20043471299130815697056
   PubMed Web of Science ®Google Scholar
• FavaMRushAJAlpertJEWhat clinical and symptom features and comorbid disorders characterize outpatients with anxious major depressive disorder: a replication and extensionCan J Psychiatry2006511382383517195602
   PubMed Web of Science ®Google Scholar
• ClaytonPJGroveWMCoryellWKellerMHirschfeldRFawcettJFollow-up and family study of anxious depressionAm J Psychiatry199114811151215171928465
   PubMed Web of Science ®Google Scholar
• PapakostasGIStahlSMKrishenAEfficacy of bupropion and the selective serotonin reuptake inhibitors in the treatment of major depressive disorder with high levels of anxiety (anxious depression): a pooled analysis of 10 studiesJ Clin Psychiatry20086981287129218605812
   PubMed Web of Science ®Google Scholar
• WiethoffKBauerMBaghaiTCPrevalence and treatment outcome in anxious versus nonanxious depression: results from the German Algorithm ProjectJ Clin Psychiatry20107181047105420673545
   PubMed Web of Science ®Google Scholar
• DunlopBWDavisPGCombination treatment with benzodiazepines and SSRIs for comorbid anxiety and depression: a reviewPrim Care Companion J Clin Psychiatry200810322222818615162
   PubMedGoogle Scholar
• BosworthHBHaysJCGeorgeLKSteffensDCPsychosocial and clinical predictors of unipolar depression outcome in older adultsInt J Geriatr Psychiatry200217323824611921152
   PubMed Web of Science ®Google Scholar
• LamRWKennedySHGrigoriadisSCanadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. III. PharmacotherapyJ Affect Disord2009117Suppl 1S26S4319674794
   PubMed Web of Science ®Google Scholar
• American Psychiatric AssociationPractice Guideline for the Treatment of Patients with Major Depressive Disorder3rd edArlington, VA, USAAmerican Psychiatric Association2010
   Google Scholar
• VietaEValentíMPharmacological management of bipolar depression: acute treatment, maintenance, and prophylaxisCNS Drugs201327751552923749421
   PubMed Web of Science ®Google Scholar
• ChouinardGIssues in the clinical use of benzodiazepines: potency, withdrawal, and reboundJ Clin Psychiatry200465Suppl 571215078112
   PubMed Web of Science ®Google Scholar
• RakofskyJJDunlopBWTreating nonspecific anxiety and anxiety disorders in patients with bipolar disorder: a reviewJ Clin Psychiatry2011721819021208580
   PubMed Web of Science ®Google Scholar
• PerlisRHOstacherMJMiklowitzDJBenzodiazepine use and risk of recurrence in bipolar disorder: a STEP-BD reportJ Clin Psychiatry201071219420020193647
   PubMed Web of Science ®Google Scholar
• BoboWVReilly-HarringtonNAKetterTAEffect of adjunctive benzodiazepines on clinical outcomes in lithium- or quetiapine-treated outpatients with bipolar I or II disorder: results from the Bipolar CHOICE trialJ Affect Disord20141616303524751304
   PubMed Web of Science ®Google Scholar
• NivoliAMColomFMurruANew treatment guidelines for acute bipolar depression: a systematic reviewJ Affect Disord20111291–3142620538341
   PubMed Web of Science ®Google Scholar
• NivoliAMMurruAGoikoleaJMNew treatment guidelines for acute bipolar mania: a critical reviewJ Affect Disord2012140212514122100133
   PubMed Web of Science ®Google Scholar
• GoodwinGMConsensus Group of the British Association for PsychopharmacologyEvidence-based guidelines for treating bipolar disorder: revised second edition-recommendations from the British Association for PsychopharmacologyJ Psychopharmacol200923434638819329543
   PubMed Web of Science ®Google Scholar
• GrunzeHVietaEGoodwinGMThe World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2010 on the treatment of acute bipolar depressionWorld J Biol Psychiatry20101128110920148751
   PubMed Web of Science ®Google Scholar
• YathamLNKennedySHParikhSVCanadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013Bipolar Disord201315114423237061
   PubMed Web of Science ®Google Scholar
• HirschfeldRMAGuideline Watch: Practice Guideline for the Treatment of Patients with Bipolar DisorderArlington, VA, USAAmerican Psychiatric Association2005
   Google Scholar
• National Institute for Health and Care ExcellenceNICE clinical guideline 38. Bipolar disorder: the management of bipolar disorder in adults, children and adolescents, in primary and secondary care2014 Available from: http://www.nice.org.uk/guidance/cg38Accessed June 5, 2015
   Google Scholar
• MalhiGSAdamsDCahillCMDoddSBerkMThe management of individuals with bipolar disorder: a review of the evidence and its integration into clinical practiceDrugs200969152063210119791827
   PubMed Web of Science ®Google Scholar
• GagratDHamiltonJBelmakerRHIntravenous diazepam in the treatment of neuroleptic-induced acute dystonia and akathisiaAm J Psychiatry1978135101232123329498
   PubMed Web of Science ®Google Scholar
• TondaMEGuthrieSKTreatment of acute neuroleptic-induced movement disordersPharmacotherapy19941455435607997388
   PubMed Web of Science ®Google Scholar
• CorteseLPourcher-BouchardEWilliamsRAssessment and management of antipsychotic-induced adverse eventsCan J Psychiatry199843Suppl 1S15S20
   Web of Science ®Google Scholar
• KumarVA case of neuroleptic malignant syndrome treated with diazepamCan J Psychiatry19873298158163435890
   PubMed Web of Science ®Google Scholar
• GerdingLBLabbateLAUse of clonazepam in an elderly bipolar patient with tardive dyskinesia: a case reportAnn Clin Psychiatry1999112878910440526
   PubMedGoogle Scholar
• IqbalMMSobhanTRyalsTEffects of commonly used benzodiazepines on the fetus, the neonate and the nursing infantPsychiatr Serv2002531394911773648
   PubMed Web of Science ®Google Scholar
• LimaARSoares-WeiserKBacaltchukJBarnesTRBenzodiazepines for neuroleptic-induced acute akathisiaCochrane Database Syst Rev20021CD00195011869614
   PubMedGoogle Scholar
• BhoopathiPSSoares-WeiserKBenzodiazepines for neuroleptic-induced tardive dyskinesiaCochrane Database Syst Rev20063CD00020516855954
   PubMedGoogle Scholar
• RosebushPIMazurekMFDo benzodiazepines modify the incidence of neuroleptic-induced dystonia?Am J Psychiatry199315035285298094602
   PubMed Web of Science ®Google Scholar
• ShapleskeJMickayAPMcKennaPJSuccessful treatment of tardive dystonia with clozapine and clonazepamBr J Psychiatry199616845165188730951
   PubMed Web of Science ®Google Scholar
• KontaxakisVPChristodoulouGNMarkidisMPHavaki-KontaxakiBJTreatment of a mild form of neuroleptic malignant syndrome with oral diazepamActa Psychiatr Scand19887833963983195360
   PubMed Web of Science ®Google Scholar
• MiyaokaHShishikuraKOtsuboTMuramatsuDKamijimaKDiazepam-responsive neuroleptic malignant syndrome: a diagnostic subtype?Am J Psychiatry199715468829167524
   PubMed Web of Science ®Google Scholar
• FrancisAChandragiriSRizviSKochMPetridesGIs lorazepam a treatment for neuroleptic malignant syndrome?CNS Spectr200057545718197156
   PubMedGoogle Scholar
• TsaiMCHuangTLSevere neuroleptic malignant syndrome: successful treatment with high-dose lorazepam and diazepam: a case reportChang Gung Med J201033557658020979709
   PubMedGoogle Scholar
• American Psychiatric AssociationDiagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text RevisionWashington, DC, USAAmerican Psychiatric Association2000
   Google Scholar
• American Psychiatric AssociationDiagnostic and Statistical Manual of Mental Disorders: DSM-5Washington, DC, USAAmerican Psychiatric Publishing Incorporated2013
   Google Scholar
• Dell’OssoBAltamuraACAllenAMarazzitiDHollanderEEpidemiologic and clinical updates on impulse control disorders: a critical reviewEur Arch Psychiatry Clin Neurosci2006256846447516960655
   PubMed Web of Science ®Google Scholar
• AzcarateCLMinor tranquilizers in the treatment of aggressionJ Nerv Ment Dis19751602-1100107235008
   PubMed Web of Science ®Google Scholar
• CitromeLVolavkaJPharmacological management of acute and persistent aggression in forensic psychiatry settingsCNS Drugs201125121009102122133324
   PubMed Web of Science ®Google Scholar
• DietchJTJenningsRKAggressive dyscontrol in patients treated with benzodiazepinesJ Clin Psychiatry19884951841882896665
   PubMed Web of Science ®Google Scholar
• AlbrechtBStaigerPKHallKMillerPBestDLubmanDIBenzodiazepine use and aggressive behaviour: a systematic reviewAust N Z J Psychiatry201448121096111425183003
   PubMed Web of Science ®Google Scholar
• FaltusFJThe positive effect of alprazolam in the treatment of three patients with borderline personality disorderAm J Psychiatry198414168028036145360
   PubMed Web of Science ®Google Scholar
• FreinharJPAlvarezWAClonazepam: a novel therapeutic adjunctInt J Psychiatry Med19851986154321328
   Web of Science ®Google Scholar
• CowdryRWGardnerDLPharmacotherapy of borderline personality disorder. Alprazolam, carbamazepine, trifluoperazine, and tranylcypromineArch Gen Psychiatry19884521111193276280
   PubMed Web of Science ®Google Scholar
• American Psychiatric AssociationPractice guideline for the treatment of patients with borderline personality disorderAm J Psychiatry200115810 Suppl152
   Web of Science ®Google Scholar
• National Institute for Clinical ExcellenceNICE clinical guideline 78. Borderline personality disorder: treatment and management2009 Available from: https://www.nice.org.uk/guidance/cg78Accessed June 5, 2015
   Google Scholar
• KnappichMHörz-SagstetterSSchwerthöfferDLeuchtSRentropMPharmacotherapy in the treatment of patients with borderline personality disorder: results of a survey among psychiatrists in private practicesInt Clin Psychopharmacol201429422422824896541
   PubMed Web of Science ®Google Scholar
• PascualJCMartín-BlancoASolerJA naturalistic study of changes in pharmacological prescription for borderline personality disorder in clinical practice: from APA to NICE guidelinesInt Clin Psychopharmacol201025634935520838221
   PubMed Web of Science ®Google Scholar
• ZanariniMCFrankenburgFRHennenJSilkKRMental health service utilization by borderline personality disorder patients and Axis II comparison subjects followed prospectively for 6 yearsJ Clin Psychiatry2004651283614744165
   PubMed Web of Science ®Google Scholar
• American Psychiatric AssociationTreatment of patients with eating disorders, third editionAm J Psychiatry20061637 Suppl45416925191
   PubMed Web of Science ®Google Scholar
• AignerMTreasureJKayeWKasperSWFSBP task force on eating disorders. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of eating disordersWorld J Biol Psychiatry201112640044321961502
   PubMed Web of Science ®Google Scholar
• HayPChinnDForbesDRoyal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the treatment of eating disordersAust N Z J Psychiatry20144811977100825351912
   PubMed Web of Science ®Google Scholar
• National Institute for Clinical ExcellenceNICE clinical guideline 9. Eating disorders: core interventions in the treatment and management of anorexia nervosa, bulimia nervosa and related eating disorders2004 Available from: http://www.nice.org.uk/guidance/cg9/evidence/cg9-eating-disorders-full-guideline-2Accessed June 5, 2015
   Google Scholar
• PallisterEWallerGAnxiety in the eating disorders: understanding the overlapClin Psychol Rev200828336638617707562
   PubMed Web of Science ®Google Scholar
• AndersenAEContrast and comparison of behavioral, cognitive-behavioral, and comprehensive treatment methods for anorexia nervosa and bulimia nervosaBehav Modif19871145225433334130
   PubMed Web of Science ®Google Scholar
• HoldernessCCBrooks-GunnJWarrenMPCo-morbidity of eating disorders and substance abuse review of the literatureInt J Eat Disord19941611147920577
   PubMed Web of Science ®Google Scholar
• DavisCClaridgeGThe eating disorders as addiction: a psychobiological perspectiveAddict Behav19982234634759698975
   PubMed Web of Science ®Google Scholar
• KayeWHWierengaCEBailerUFDoes a shared neurobiology for foods and drugs of abuse contribute to extremes of food ingestion in anorexia and bulimia nervosa?Biol Psychiatry201373983684223380716
   PubMed Web of Science ®Google Scholar
• StunkardAJGraceWJWolffHGThe night-eating syndrome: a pattern of food intake among certain obese patientsAm J Med1955191788614388031
   PubMed Web of Science ®Google Scholar
• VinaiPAllisonKCCardettiSPsychopathology and treatment of night eating syndrome: a reviewEat Weight Disord2008132546318612253
   PubMed Web of Science ®Google Scholar
• AllisonKCWaddenTASarwerDBNight eating syndrome and binge eating disorder among persons seeking bariatric surgery: prevalence and related featuresSurg Obes Relat Dis20062215315816925341
   PubMed Web of Science ®Google Scholar
• AllisonKCTarvesETreatment of night eating syndromePsychiatr Clin North Am201134478579622098804
   PubMed Web of Science ®Google Scholar
• CarràGJohnsonSVariations in rates of comorbid substance use in psychosis between mental health settings and geographical areas in the UK. A systematic reviewSoc Psychiatry Psychiatr Epidemiol200944642944719011722
   PubMed Web of Science ®Google Scholar
• CarràGJohnsonSBebbingtonPThe lifetime and past-year prevalence of dual diagnosis in people with schizophrenia across Europe: findings from the European Schizophrenia Cohort (EuroSC)Eur Arch Psychiatry Clin Neurosci2012262760761622427152
   PubMed Web of Science ®Google Scholar
• CarràGScioliRMontiMCMarinoniASeverity profiles of substance-abusing patients in Italian community addiction facilities: influence of psychiatric concurrent disordersEur Addict Res20061229610116543745
   PubMed Web of Science ®Google Scholar
• NuttDKingLASaulsburyWBlakemoreCDevelopment of a rational scale to assess the harm of drugs of potential misuseLancet200736995661047105317382831
   PubMed Web of Science ®Google Scholar
• ComptonWMVolkowNDAbuse of prescription drugs and the risk of addictionDrug Alcohol Depend200683Suppl 1S4S716563663
   PubMed Web of Science ®Google Scholar
• BrunetteMFNoordsyDLXieHDrakeREBenzodiazepine use and abuse among patients with severe mental illness and co-occurring substance use disordersPsychiatr Serv200354101395140114557527
   PubMed Web of Science ®Google Scholar
• ClarkREXieHBrunetteMFBenzodiazepine prescription practices and substance abuse in persons with severe mental illnessJ Clin Psychiatry200465215115515003066
   PubMed Web of Science ®Google Scholar
• LinSCChenCCChenYHChungKSLinCHBenzodiazepine prescription among patients with severe mental illness and co-occurring alcohol abuse/dependence in TaiwanHum Psychopharmacol201126320120721671270
   PubMed Web of Science ®Google Scholar
• LavieEFatséasMDenisCAuriacombeMBenzodiazepine use among opiate-dependent subjects in buprenorphine maintenance treatment: correlates of use, abuse and dependenceDrug Alcohol Depend2009991–333834418824311
   PubMed Web of Science ®Google Scholar
• CarràGCrocamoCBorrelliPCorrelates of dependence and treatment for substance use among people with comorbid severe mental and substance use disorders. Findings from the “Psychiatric and Addictive Dual Disorder in Italy (PADDI)” StudyCompr Psychiatry20155815215925591906
   PubMed Web of Science ®Google Scholar
• National Collaborating Centre for Mental Health (National Institute for Health and Care Excellence)NICE clinical guideline 120. Psychosis with Coexisting Substance Misuse: Assessment and Management in Adults and Young People2011 Available from: http://www.nice.org.uk/guidance/cg120/chapter/guidanceAccessed June 5, 2015
   Google Scholar
• Lingford-HughesARWelchSPetersLBAP updated guidelines: evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from BAPJ Psychopharmacol201226789995222628390
   PubMed Web of Science ®Google Scholar
• SchifanoFDelucaPAgostiLNew trends in the cyber and street market of recreational drugs? The case of 2C-T-7 (“Blue Mystic”)J Psychopharmacol200519667567916272191
   PubMed Web of Science ®Google Scholar
• CorazzaOAssiSSimonatoPPromoting innovation and excellence to face the rapid diffusion of novel psychoactive substances in the EU: the outcomes of the ReDNet projectHum Psychopharmacol201328431732323881879
   PubMed Web of Science ®Google Scholar
• EnglandRDholakiaNTukmachiEReplace clonazepam with an alternative antiepileptic drug to reduce drug misuseBMJ2012345e780923166077
   PubMed Web of Science ®Google Scholar
• SimmonsMMCuppMJUse and abuse of flunitrazepamAnn Pharmacother19983211171199475831
   PubMed Web of Science ®Google Scholar
• DarganPIDaviesSPuchnarewiczMJohnstonAWoodDMFirst reported case in the UK of acute prolonged neuropsychiatric toxicity associated with analytically confirmed recreational use of phenazepamEur J Clin Pharmacol201369336136322843017
   PubMed Web of Science ®Google Scholar
• RamadanASWenanuOCockADMaesVLheureuxPMolsPChemical submission to commit robbery: a series of involuntary intoxications with flunitrazepam in Asian travellers in BrusselsJ Forensic Leg Med201320791892124112346
   PubMed Web of Science ®Google Scholar
• OhshimaTA case of drug-facilitated sexual assault by the use of flunitrazepamJ Clin Forensic Med2006131444516087387
   PubMedGoogle Scholar
• MartinottiGLupiMAcciavattiTNovel psychoactive substances in young adults with and without psychiatric comorbiditiesBiomed Res Int2014201481542425133182
   PubMed Web of Science ®Google Scholar
• CorkeryJMSchifanoFGhodseAHPhenazepam abuse in the UK: an emerging problem causing serious adverse health problems, including deathHum Psychopharmacol201227325426122407587
   PubMed Web of Science ®Google Scholar
• TangMHChingCKTsuiMSChuFKMakTWTwo cases of severe intoxication associated with analytically confirmed use of the novel psychoactive substances 25B-NBOMe and 25C-NBOMeClin Toxicol (Phila)201452556156524779864
   PubMed Web of Science ®Google Scholar
• GoedersNEGuerinGFSchmoutzCDThe combination of metyrapone and oxazepam for the treatment of cocaine and other drug addictionsAdv Pharmacol20146941947924484984
   PubMedGoogle Scholar
• SellersEMCirauloDADuPontRLAlprazolam and benzodiazepine dependenceJ Clin Psychiatry19931054 Suppl64758262891
   PubMed Web of Science ®Google Scholar
• MartinottiGPregabalin in clinical psychiatry and addiction: pros and consExpert Opin Investig Drugs201221912431245
   PubMed Web of Science ®Google Scholar
• NgCGBoksMPSmeetsHMZainalNZde WitNJPrescription patterns for psychotropic drugs in cancer patients; a large population study in the NetherlandsPsychooncology2013224462467
   Web of Science ®Google Scholar
• CarusoRGrassiLNanniMGRibaMPsychopharmacology in psycho-oncologyCurr Psychiatry Rep201315939323949568
   PubMed Web of Science ®Google Scholar
• GrassiLCarusoRHammelefKNanniMGRibaMEfficacy and safety of pharmacotherapy in cancer-related psychiatric disorders across the trajectory of cancer care: a reviewInt Rev Psychiatry2014261446224716500
   PubMed Web of Science ®Google Scholar
• TestaAGiannuzziRSollazzoFPetrongoloLBernardiniLDainSPsychiatric emergencies (part II): psychiatric disorders coexisting with organic diseasesEur Rev Med Pharmacol Sci201317Suppl 1658523436669
   PubMed Web of Science ®Google Scholar
• NielsenSLintzerisNCampbellGBenzodiazepine use among chronic pain patients prescribed opioids: associations with pain, physical and mental health, and health service utilizationPain Med201516235636625279706
   PubMed Web of Science ®Google Scholar
• TraegerLGreerJAFernandez-RoblesCTemelJSPirlWFEvidence-based treatment of anxiety in patients with cancerJ Clin Oncol201230111197120522412135
   PubMed Web of Science ®Google Scholar
• StiefelFBerneyAMazzocatoCPsychopharmacology in supportive care in cancer: a review for the clinician. I. BenzodiazepinesSupport Care Cancer19997637938510541978
   PubMed Web of Science ®Google Scholar
• RothAJMassieMJAnxiety in palliative careChochinovHMBreitbartWHandbook of Psychiatry in Palliative Medicine2nd edOxford, UKOxford University Press20126980
   Google Scholar
• MalikIAKhanWAQazilbashMAtaEButtAKhanMAClinical efficacy of lorazepam in prophylaxis of anticipatory, acute, and delayed nausea and vomiting induced by high doses of cisplatin. A prospective randomized trialAm J Clin Oncol19951821701757900711
   PubMed Web of Science ®Google Scholar
• AbaliHOyanBGulerNAlprazolam significantly improves the efficacy of granisetron in the prophylaxis of emesis secondary to moderately emetogenic chemotherapy in patients with breast cancerChemotherapy200551528028516103667
   PubMed Web of Science ®Google Scholar
• WangFShenSRXiaoDHXuCXTangWLSedation, analgesia, and cardiorespiratory function in colonoscopy using midazolam combined with fentanyl or propofolInt J Colorectal Dis201126670370821409424
   PubMed Web of Science ®Google Scholar
• FerrariLCaraceniASedation for psychological distress at the end of lifeGrassiLRibaMPsychopharmacology in Oncology and Palliative CareNew York, NY, USASpringer2014369380
   Google Scholar
• BhugraDGuptaSSchouler-OcakMEPA guidance mental health care of migrantsEur Psychiatry201429210711524503244
   PubMed Web of Science ®Google Scholar
• VelingWHoekHWMackenbachJPPerceived discrimination and the risk of schizophrenia in ethnic minoritiesSoc Psychiatry Psychiatr Epidemiol2008431295395918575790
   PubMed Web of Science ®Google Scholar
• BoydellJvan OsJMcKenzieKIncidence of schizophrenia in ethnic minorities in London: ecological study into interactions with environmentBMJ200132373251336133811739218
   PubMed Web of Science ®Google Scholar
• MantheyLGiltayEJvan VeenTNevenAKZitmanFGPenninxBWDeterminants of initiated and continued benzodiazepine use in the Netherlands study of depression and anxietyJ Clin Psychopharmacol201131677477922020355
   PubMed Web of Science ®Google Scholar
• MelfiCACroghanTWHannaMPRobinsonRLRacial variation in antidepressant treatment in a Medicaid populationJ Clin Psychiatry2000611162110695640
   PubMed Web of Science ®Google Scholar
• HusainNWaheedWTomensonBCreedFThe validation of personal health questionnaire amongst people of Pakistani family origin living in the United KingdomJ Affect Disord2007971–326126416860397
   PubMed Web of Science ®Google Scholar
• TarriconeIStivanelloEFerrariSMigrant pathways to community mental health centres in ItalyInt J Soc Psychiatry201258550551121813479
   PubMed Web of Science ®Google Scholar
• TarriconeIStivanelloEPoggiFEthnic variation in the prevalence of depression and anxiety in primary care: a systematic review and meta-analysisPsychiatry Res201219539110621705094
   PubMed Web of Science ®Google Scholar
• World Health OrganizationPreventing suicide: a global imperativeGeneva, SwitzerlandWorld Health Organization2014 Available from: http://apps.who.int/iris/bitstream/10665/131056/1/9789241564779_eng.pdfAccessed June 5, 2015
   Google Scholar
• FawcettJScheftnerWAFoggLTime-related predictors of suicide in major affective disorderAm J Psychiatry19901479118911942104515
   PubMed Web of Science ®Google Scholar
• ShihHILinMCLinCCBenzodiazepine therapy in psychiatric outpatients is associated with deliberate self-poisoning events at emergency departments – a population-based nested case-control studyPsychopharmacology2013229466567123657424
   PubMed Web of Science ®Google Scholar
• NeutelCIPattenSBRisk of suicide attempts after benzodiazepine and/or antidepressant useAnn Epidemiol1997785685749408553
   PubMed Web of Science ®Google Scholar
• KhanALeventhalRMKhanSBrownWASuicide risk in patients with anxiety disorders: a meta-analysis of the FDA databaseJ Affect Disord2002682–318319012063146
   PubMed Web of Science ®Google Scholar
• American Psychiatric AssociationPractice guideline for the assessment and treatment of patients with suicidal behaviorsArlington, VA, USAAmerican Psychiatric Association2003 Available from: http://psychiatryonline.org/pb/assets/raw/sitewide/practice_guidelines/guidelines/suicide.pdfAccessed June 6, 2015
   Google Scholar
• GaertnerIGilotCHeidrichPGaertnerHJA case control study on psychopharmacotherapy before suicide committed by 61 psychiatric inpatientsPharmacopsychiatry2002352374311951144
   PubMed Web of Science ®Google Scholar
• JoughinNTataPCollinsMHooperCFalkowskiJIn-patient withdrawal from long-term benzodiazepine useBr J Addict19918644494551675899
   PubMedGoogle Scholar
• BarbuiCGregisMZappaMA cross-sectional audit of benzodiazepine use among general practice patientsActa Psychiatr Scand19989721531569517911
   PubMed Web of Science ®Google Scholar
• OwenJAPsychopharmacologyLevensonJLTextbook of Psychosomatic Medicine Psychiatric Care of the Medically IllWashington, DC, USAAmerican Psychiatric Publishing20119571020
   Google Scholar
• De BellisRSmithBSChoiSMalloyMManagement of delirium tremensJ Intensive Care Med200520316417315888905
   PubMedGoogle Scholar
• American Geriatric SocietyAmerican Geriatric Society updated Beers criteria for potentially inappropriate medication use in older adultsJ Am Geriatr Soc201260461663122376048
   PubMed Web of Science ®Google Scholar
• FosnesGLydersenSFarupPGDrugs and constipation in elderly in nursing homes: what is the relation?Gastroenterol Res Pract2012201229023122505881
   PubMed Web of Science ®Google Scholar
• VerhammeKSturkenboomMStrickerBBoschRDrug-induced urinary retention: incidence, management and preventionDrug Saf200831537338818422378
   PubMed Web of Science ®Google Scholar
• van StrienemailAKoekHvan MarumREmmelot-VonkMPsychotropic medications, including short acting benzodiazepines, strongly increase the frequency of falls in elderlyMaturitas201374435736223375674
   PubMed Web of Science ®Google Scholar
• BiermanEComijsHGundyCSonnenbergCJonkerCBeekmanAThe effect of chronic benzodiazepine use on cognitive functioning in older persons: good, bad or indifferent?Int J Geriatr Psychiatry20072212194200
   Web of Science ®Google Scholar
• Billioti de GageSMorideYDucruetTBenzodiazepine use and risk of Alzheimer’s disease: case-control studyBMJ2014349g520525208536
   PubMed Web of Science ®Google Scholar
• YaffeKScolaMBoustaniMFairbanksRBenzodiazepines and risk of Alzheimer diseaseBMJ2014349g531225205606
   PubMed Web of Science ®Google Scholar
• MelzerDTavakolyBWinderRMuch more medicine for the oldest old: trends in UK electronic clinical recordsAge Ageing2015441465325103030
   PubMed Web of Science ®Google Scholar
• ZisookSBalonRBenjaminSPsychopharmacology curriculum field testAcad Psychiatry200933535836319828846
   PubMed Web of Science ®Google Scholar
• JeffersonJWOld versus new medications. How much should be taught?Acad Psychiatry200529216216615937262
   PubMed Web of Science ®Google Scholar
• BenjaminDSwartzMFormanLThe impact of evidence-based education on prescribing in a psychiatry residencyJ Psychiatr Pract201117211011721430489
   PubMed Web of Science ®Google Scholar
• FiorilloALucianoMGiaccoDTraining and practice of psychotherapy in Europe: results of a surveyWorld Psychiatry201110323821991286
   PubMed Web of Science ®Google Scholar
• AnthierensSHabrakenHPetrovicMChristiaensTThe lesser evil? Initiating a benzodiazepine prescription in general practice: a qualitative study on GPs’ perspectivesScand J Prim Health Care200725421421918041658
   PubMed Web of Science ®Google Scholar
• SirdifieldCAnthierensSCreupelandtHChipchaseSYChristiaensTSiriwardenaANGeneral practitioners’ experiences and perceptions of benzodiazepine prescribing: systematic review and meta-synthesisBMC Fam Pract20131419124330388
   PubMed Web of Science ®Google Scholar
• HoffmannFBenefits and risks of benzodiazepines and Z-drugs: comparison of perceptions of GPs and community pharmacists in GermanyGer Med Sci201311Doc1023904824
   PubMedGoogle Scholar
• TannenbaumCPaquetteAHilmerSHolroyd-LeducJCarnahanRA systematic review of amnestic and non-amnestic mild cognitive impairment induced by anticholinergic, antihistamine, GABAergic and opioid drugsDrugs Aging201229863965822812538
   PubMed Web of Science ®Google Scholar
• BarkerMJGreenwoodKMJacksonMCroweSFCognitive effects of long-term benzodiazepine useCNS Drugs2004181374814731058
   PubMed Web of Science ®Google Scholar
• BarkerMJGreenwoodKMJacksonMCroweSFPersistence of cognitive effects after withdrawal from long-term benzodiazepine use: a meta-analysisArch Clin Neuropsychol200419343745415033227
   PubMed Web of Science ®Google Scholar
• MantheyLvan Loenen-FröschFGiltayEJHigh dose benzodiazepines prolong reaction times in chronic users who have major depressive and/or anxiety disordersBr J Clin Pharmacol201477357157723962205
   PubMed Web of Science ®Google Scholar
• VerdouxHLagnaouiRBegaudBIs benzodiazepine use a risk factor for cognitive decline and dementia? A literature review of epidemiological studiesPsychol Med200535330731515841867
   PubMed Web of Science ®Google Scholar
• LagnaouiRTournierMMorideYThe risk of cognitive impairment in older community-dwelling women after benzodiazepine useAge Ageing200938222622819066367
   PubMed Web of Science ®Google Scholar
• OlfsonMKingMSchoenbaumMBenzodiazepines use in the United StatesJAMA Psychiatry201572213614225517224
   PubMed Web of Science ®Google Scholar
• LeungSYBenzodiazepines, opioids and driving: an overview of the experimental researchDrug Alcohol Rev201130328128621545558
   PubMed Web of Science ®Google Scholar
• RapoportMJLanctotKLStreinerDLBenzodiazepine use and driving: a meta-analysisJ Clin Psychiatry200970566367319389334
   PubMed Web of Science ®Google Scholar
• ChangCMWuECChenCYPsychotropic drugs and risk of motor vehicle accidents: a population-based case-control studyBr J Clin Pharmacol20137541125113322971090
   PubMed Web of Science ®Google Scholar
• WagnerAKZhangFSoumeraiSBBenzodiazepine use and hip fractures in the elderly: who is at greatest risk?Arch Intern Med2004164141567157215277291
   PubMed Web of Science ®Google Scholar
• de VriesOJPeetersGEldersPThe elimination half-life of benzodiazepines and fall risk: two prospective observational studiesAge Ageing201342676477023900130
   PubMed Web of Science ®Google Scholar
• BoltonJMMetgeCLixLPriorHSareenJLeslieWDFracture risk from psychotropic medications: a population-based analysisJ Clin Psychopharmacol200828438439118626264
   PubMed Web of Science ®Google Scholar
• PatonCBenzodiazepines and disinhibition: a reviewPsychiatr Bull20022612460462
   Google Scholar
• MancusoCETanziMGGabayMParadoxical reactions to benzodiazepines: literature review and treatment optionsPharmacotherapy20042491177118515460178
   PubMed Web of Science ®Google Scholar
• BondAJDrug-induced behavioural disinhibition: incidence, mechanisms and therapeutic implicationsCNS Drugs1998914157
   Web of Science ®Google Scholar
• KanCCBretelerMHZitmanFGHigh prevalence of benzodiazepine dependence in out-patient users, based on the DSM-III-R and ICD-10 criteriaActa Psychiatr Scand199796285939272191
   PubMed Web of Science ®Google Scholar
• LaderMBenzodiazepine harm: how can it be reduced?Br J Clin Pharmacol201477229530122882333
   PubMed Web of Science ®Google Scholar
• JohnsonCBaxterBBroughRBuchananJBenzodiazepine prescribing: lessons from interprofessional dialogueAust Fam Physician200736424524617392937
   PubMedGoogle Scholar
• DolovichLRAddisAVaillancourtJMPowerJDKorenGEinarsonTRBenzodiazepine use in pregnancy and major malformations or oral cleft: meta-analysis of cohort and case-control studiesBMJ199831771628398439748174
   PubMed Web of Science ®Google Scholar
• ErosECzeizelAERockenbauerMSorensenHTOlsenJA population-based case-control teratologic study of nitrazepam, medazepam, tofisopam, alprazolum and clonazepam treatment during pregnancyEur J Obstet Gynecol Reprod Biol2002101214715411858890
   PubMed Web of Science ®Google Scholar
• BellantuonoCTofaniSDi SciascioGSantoneGBenzodiazepine exposure in pregnancy and risk of major malformations: a critical overviewGen Hosp Psychiatry20133513823044244
   PubMed Web of Science ®Google Scholar
• MainaGSaraccoPGiolitoMRDanelonDBogettoFTodrosTImpact of maternal psychological distress on fetal weight, prematurity and intrauterine growth retardationJ Affect Disord20081112–321422018394713
   PubMed Web of Science ®Google Scholar
• KellyLEPoonSMadadiPKorenGNeonatal benzodiazepines exposure during breastfeedingJ Pediatr2012161344845122504099
   PubMed Web of Science ®Google Scholar
• FiorilloALucianoMDel VecchioVPriorities for mental health research in Europe: a survey among national stakeholders’ associations within the ROAMER projectWorld Psychiatry201312216517023737426
   PubMed Web of Science ®Google Scholar